Oklo Publishes Third Quarter 2025 Financial Results and Business Update
SANTA CLARA, Calif., November 11, 2025--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today...
SANTA CLARA, Calif., November 11, 2025--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo" or "the Company"), an advanced nuclear technology company, today...
Evaxion Correcting press release issued under same heading: Date in body text corrected to "November 6, 2025" as in headline....
Company to host conference call and webcast today at 8:30 a.m. EDT CARMIEL, Israel, Aug. 14, 2025 /PRNewswire/ -- Protalix...
SANTA CLARA, Calif., July 28, 2025--(BUSINESS WIRE)--Oklo Inc. (NYSE: OKLO) ("Oklo," or "the Company"), an advanced nuclear technology company, today...
TEL AVIV, Israel, May 22, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical...
Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and development of innovative...